Intel [INTC] vs Texas Instruments [TXN] Detailed Stock Comparison
Intel
NASDAQ
Loading...
Texas Instruments
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Intel wins in 7 metrics, Texas Instruments wins in 12 metrics, with 0 ties. Texas Instruments appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Intel | Texas Instruments | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 89.67 | 33.47 | Texas Instruments |
| Price-to-Book Ratio | 0.89 | 10.13 | Intel |
| Debt-to-Equity Ratio | 48.00 | 85.61 | Intel |
| PEG Ratio | 20.57 | 31.08 | Intel |
| EV/EBITDA | 13.47 | 23.28 | Intel |
| Profit Margin (TTM) | -38.64% | 30.23% | Texas Instruments |
| Operating Margin (TTM) | -3.80% | 35.03% | Texas Instruments |
| EBITDA Margin (TTM) | N/A | 35.03% | N/A |
| Return on Equity | -18.62% | 29.99% | Texas Instruments |
| Return on Assets (TTM) | -0.85% | 10.41% | Texas Instruments |
| Free Cash Flow (TTM) | $-15.66B | $1.50B | Texas Instruments |
| Dividend Yield | 0.56% | 3.11% | Texas Instruments |
| 1-Year Return | 1.22% | -2.60% | Intel |
| Price-to-Sales Ratio (TTM) | 1.65 | 9.96 | Intel |
| Enterprise Value | $123.95B | $174.81B | Texas Instruments |
| EV/Revenue Ratio | 2.34 | 10.48 | Intel |
| Gross Profit Margin (TTM) | 27.54% | 57.89% | Texas Instruments |
| Revenue per Share (TTM) | $12 | $18 | Texas Instruments |
| Earnings per Share (Diluted) | $-4.77 | $5.46 | Texas Instruments |
| Beta (Stock Volatility) | 1.22 | 1.02 | Texas Instruments |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Intel vs Texas Instruments Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Intel | 0.91% | 3.31% | -15.43% | -5.00% | 0.91% | -1.34% |
| Texas Instruments | 0.70% | 3.52% | -13.58% | 13.03% | 3.83% | 0.14% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Intel | 1.22% | -44.75% | -59.19% | -31.25% | 4.18% | -24.17% |
| Texas Instruments | -2.60% | 0.99% | 36.31% | 269.71% | 671.09% | 488.93% |
Performance & Financial Health Analysis: Intel vs Texas Instruments
| Metric | INTC | TXN |
|---|---|---|
| Market Information | ||
| Market Cap | $87.32B | $166.13B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 85,978,501 | 10,273,420 |
| 90 Day Avg. Volume | 84,325,934 | 7,068,330 |
| Last Close | $19.95 | $187.22 |
| 52 Week Range | $17.67 - $27.55 | $139.95 - $221.69 |
| % from 52W High | -27.59% | -15.55% |
| All-Time High | $75.83 (Aug 21, 2000) | $221.69 (Jul 11, 2025) |
| % from All-Time High | -73.69% | -15.55% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.00% | 0.16% |
| Quarterly Earnings Growth | 0.00% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.39% | 0.30% |
| Operating Margin (TTM) | -0.04% | 0.35% |
| Return on Equity (TTM) | -0.19% | 0.30% |
| Debt to Equity (MRQ) | 48.00 | 85.61 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $22.36 | $18.05 |
| Cash per Share (MRQ) | $4.85 | $5.90 |
| Operating Cash Flow (TTM) | $10.08B | $6.44B |
| Levered Free Cash Flow (TTM) | $-8,320,625,152 | $-1,568,999,936 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.56% | 3.11% |
| Last 12-Month Dividend | $0.12 | $6.74 |
Valuation & Enterprise Metrics Analysis: Intel vs Texas Instruments
| Metric | INTC | TXN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 89.67 | 33.47 |
| Forward P/E | 20.57 | 31.08 |
| PEG Ratio | 20.57 | 31.08 |
| Price to Sales (TTM) | 1.65 | 9.96 |
| Price to Book (MRQ) | 0.89 | 10.13 |
| Market Capitalization | ||
| Market Capitalization | $87.32B | $166.13B |
| Enterprise Value | $123.95B | $174.81B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.34 | 10.48 |
| Enterprise to EBITDA | 13.47 | 23.28 |
| Risk & Other Metrics | ||
| Beta | 1.22 | 1.02 |
| Book Value per Share (MRQ) | $22.36 | $18.05 |
Financial Statements Comparison: Intel vs Texas Instruments
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | INTC | TXN |
|---|---|---|
| Revenue/Sales | $12.67B | $4.07B |
| Cost of Goods Sold | $8.00B | $1.76B |
| Gross Profit | $4.67B | $2.31B |
| Research & Development | $3.64B | $517.00M |
| Operating Income (EBIT) | $-145.00M | $1.32B |
| EBITDA | $2.66B | $1.85B |
| Pre-Tax Income | $-586.00M | $1.28B |
| Income Tax | $301.00M | $97.00M |
| Net Income (Profit) | $-887.00M | $1.18B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | INTC | TXN |
|---|---|---|
| Cash & Equivalents | $8.95B | $2.76B |
| Total Current Assets | $42.13B | $13.09B |
| Total Current Liabilities | $32.17B | $2.49B |
| Long-Term Debt | $44.91B | $12.85B |
| Total Shareholders Equity | $106.41B | $16.41B |
| Retained Earnings | $48.32B | $52.20B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | INTC | TXN |
|---|---|---|
| Operating Cash Flow | $1.44B | $1.15B |
| Capital Expenditures | $-5.18B | N/A |
| Free Cash Flow | $-4.37B | $-274.00M |
| Debt Repayment | $-1.50B | $-750.00M |
| Common Stock Repurchase | N/A | $-653.00M |
Short Interest & Institutional Ownership Analysis
| Metric | INTC | TXN |
|---|---|---|
| Shares Short | 121.71M | 16.99M |
| Short Ratio | 1.45 | 3.03 |
| Short % of Float | 0.03% | 0.02% |
| Average Daily Volume (10 Day) | 85,978,501 | 10,273,420 |
| Average Daily Volume (90 Day) | 84,325,934 | 7,068,330 |
| Shares Outstanding | 4.33B | 911.22M |
| Float Shares | 4.37B | 906.86M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.68% | 0.91% |
Dividend Analysis & Yield Comparison: Intel vs Texas Instruments
| Metric | INTC | TXN |
|---|---|---|
| Last 12-Month Dividend | $0.12 | $6.74 |
| Last 12-Month Dividend Yield | 0.56% | 3.11% |
| 3-Year Avg Annual Dividend | $0.60 | $5.58 |
| 3-Year Avg Dividend Yield | 0.66% | 0.73% |
| 3-Year Total Dividends | $1.80 | $16.75 |
| Ex-Dividend Date | Aug 07, 2024 | Jul 31, 2025 |